Investing.com - Carl Zeiss Meditec reported on Friday second quarter earnings that matched analysts' forecasts and revenue that fell short of expectations.
Carl Zeiss Meditec announced earnings per share of €0.7 on revenue of €477.4M. Analysts polled by Investing.com anticipated EPS of €0.7 on revenue of €477.42M.
Carl Zeiss Meditec shares are down 13.05% from the beginning of the year and are trading at €125.78 , down-from-52-week-high.They are under-performing the EUR/USD which is down 0% from the start of the year.
Carl Zeiss Meditec follows other major Healthcare sector earnings this month
Carl Zeiss Meditec's report follows an earnings missed by Spire Healthcare on Thursday, who reported EPS of €-0 on revenue of €596.2M, compared to forecasts EPS of €2.80 on revenue of €590.80M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar
AFXG: is this perennial leader facing new challenges?
With valuations skyrocketing in 2024, many investors are uneasy putting more money into stocks. Sure, there are always opportunities in the stock market – but finding them feels more difficult now than a year ago. Unsure where to invest next? One of the best ways to discover new high-potential opportunities is to look at the top performing portfolios this year. ProPicks AI offers 6 model portfolios from Investing.com which identify the best stocks for investors to buy right now. For example, ProPicks AI found 9 overlooked stocks that jumped over 25% this year alone. The new stocks that made the monthly cut could yield enormous returns in the coming years. Is AFXG one of them?
Unlock ProPicks AI to find out